bw-755c has been researched along with acrolein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Hales, CA; Hutchison, WG; Janssens, SP; Jung, W; Musto, SW; Spence, C; Witten, M | 1 |
2 other study(ies) available for bw-755c and acrolein
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cyclooxygenase and lipoxygenase inhibition by BW-755C reduces acrolein smoke-induced acute lung injury.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acrolein; Animals; Benzofurans; Blood Proteins; Cyclooxygenase Inhibitors; Eicosanoids; Indomethacin; Inflammation Mediators; Lipoxygenase Inhibitors; Lymph; Oxygen Consumption; Pulmonary Circulation; Sheep; Smoke Inhalation Injury; Thromboxane-A Synthase; Vascular Resistance | 1994 |